| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/13/2010 | CA2295678C Pyridine derivatives |
| 04/08/2010 | WO2010039793A1 Hepatitis c virus inhibitors |
| 04/08/2010 | WO2010039256A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 04/08/2010 | WO2010039237A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | WO2010038465A1 8-substituted isoquinoline derivative and use thereof |
| 04/08/2010 | WO2010038167A1 Oxopiperidinyl and pyranyl sulfonamides as ampa potentiators |
| 04/08/2010 | WO2010038081A2 Heterocyclic derivatives and methods of use thereof |
| 04/08/2010 | WO2010037210A1 Viral polymerase inhibitors |
| 04/08/2010 | US20100087660 Synthesis of amines and intermediates for the synthesis thereof |
| 04/08/2010 | US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100087431 Triazolyl aminopyrimidine compounds |
| 04/08/2010 | US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 04/08/2010 | US20100087396 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 04/08/2010 | US20100086915 Detection of esr1 amplification in breast cancer |
| 04/08/2010 | CA2739322A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | CA2738768A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 04/08/2010 | CA2738563A1 8-substituted isoquinoline derivatives and the use thereof |
| 04/08/2010 | CA2738041A1 Oxopiperidinyl and pyranyl sulfonamides as ampa potentiators |
| 04/07/2010 | EP2172460A1 Compositions useful as inhibitors of JAK and other protein kinases |
| 04/07/2010 | EP2172457A2 Fredericamycin derivatives |
| 04/07/2010 | EP2172456A1 N-phenyl-methanamine derivative and pest control agent containing the same |
| 04/07/2010 | EP2172455A1 Oxime ester photoinitiators |
| 04/07/2010 | EP2170872A2 Process for the preparation of benzimidazol thienylamine compounds and intermediates thereof |
| 04/07/2010 | EP2170871A2 Processes for preparing benzimidazole thiophenes |
| 04/07/2010 | EP2170866A1 Phthalazine compounds, compositions and methods of use |
| 04/07/2010 | EP2170858A2 Novel microbiocides |
| 04/07/2010 | EP2170843A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 04/07/2010 | EP1971581B1 Piperazine compounds with a herbicidal action |
| 04/07/2010 | EP1590340B1 Inhibitors of histone deacetylase |
| 04/07/2010 | EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 04/07/2010 | CN101691354A Method for chemically synthesizing 2-heteroaryl substituted quinoline derivatives |
| 04/06/2010 | US7692029 Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7691884 Heterocyclic sulfonamide inhibitors of β amyloid production |
| 04/06/2010 | US7691853 Pyrazole compounds useful as protein kinase inhibitors |
| 04/06/2010 | US7691820 Administering a 1-(4-thio-beta-D-arabinofuranosyl)- cytosine or 5- or 6-aza compound for inhibiting replication of DNA, immunomodulation and treatment of autoimmune diseases; also claimed is 1-(4-thio- beta -D-arabinofuranosyl)-5-fluorocytosine. |
| 04/06/2010 | US7691785 Pyridine-3-ketone compound; plant growth controllers |
| 04/06/2010 | CA2252536C Ethylene derivatives and pesticides containing said derivatives |
| 04/01/2010 | WO2010036921A2 Slow release of organoboronic acids in cross-coupling reactions |
| 04/01/2010 | WO2010036497A2 Selective estrogen receptor modulator |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 04/01/2010 | WO2010034827A1 Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions |
| 04/01/2010 | WO2010034512A1 Compounds with antimalarial activity |
| 04/01/2010 | WO2010011626A3 Pyridinyl modulators of ϒ-secretase |
| 04/01/2010 | WO2010002655A3 Pyrimidine derivatives as kinase inhibitors |
| 04/01/2010 | WO2009116883A3 Catalytic asymetric hydrogenation |
| 04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 04/01/2010 | CA2738878A1 Selective estrogen receptor modulator for the treatment of osteoarthritis |
| 03/31/2010 | EP2168962A2 Phenylacetamides and their use as glucokinase modulators |
| 03/31/2010 | EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof |
| 03/31/2010 | EP2168951A1 Azolylmethylenehydrazine derivative and use thereof |
| 03/31/2010 | EP2168576A2 New utilities of tricyclic compounds |
| 03/31/2010 | EP2167496A2 Azo dyes |
| 03/31/2010 | EP2167495A1 Substituted oxazolidinones and the use thereof |
| 03/31/2010 | EP2167485A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 03/31/2010 | EP2167484A2 Condensed anthranilamide insecticides |
| 03/31/2010 | EP2167472A2 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 03/31/2010 | EP2167469A1 Sulfonyl-quinoline derivatives |
| 03/31/2010 | EP2167464A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) |
| 03/31/2010 | EP2167083A2 Novel 1- heteroaryl-3-azabicycloý3.1.0¨hexanes, methods for their preparation and their use as medicaments |
| 03/31/2010 | EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions |
| 03/31/2010 | EP2166846A1 Inhibitors of janus kinases |
| 03/31/2010 | EP2076496B1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 03/31/2010 | EP1546107B1 Cox-2 inhibiting pyridine derivatives |
| 03/31/2010 | EP1252139B1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 03/31/2010 | CN101687843A Substituted aromatic heterocyclic compounds as fungicides |
| 03/31/2010 | CN101687841A Benzimidazole derivatives |
| 03/31/2010 | CN101687837A Aromatic amine derivative and organic electroluminescent device using the same |
| 03/31/2010 | CN101687836A Novel microbiocides |
| 03/31/2010 | CN101687816A Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase |
| 03/31/2010 | CN101687807A 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 03/31/2010 | CN101687797A Malonamide derivatives with antithrombotic activity |
| 03/31/2010 | CN101687794A oxime ester photoinitiators |
| 03/31/2010 | CN101687790A Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) |
| 03/31/2010 | CN101687786A Hydroxylamine compounds and methods of their use |
| 03/31/2010 | CN101684201A Anthrapyridone dyes, their preparation and their use |
| 03/31/2010 | CN101684095A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/31/2010 | CN101684091A cannabinoid receptor ligands |
| 03/31/2010 | CN101683311A Uses of dithiolane compounds for the photoprotection of the skin, dithiolane compounds and compositions containing same |
| 03/30/2010 | US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 03/30/2010 | US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome |
| 03/30/2010 | US7687639 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/30/2010 | US7687535 Substituted 3-sulfur indoles |
| 03/30/2010 | US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders |
| 03/30/2010 | US7687502 Substituted quinazoline or pyridopyrimidine derivative |
| 03/30/2010 | US7687491 Immunosuppressants with low toxicity; 1-({4-Methyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl}methyl)azetidine-3-carboxylic acid for example; autoimmune diseases and transplant rejection; N-substituted azetidine, pyrrolidine or piperidine compounds |
| 03/30/2010 | US7687067 combating phytopathogenic fungi |
| 03/30/2010 | CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 03/30/2010 | CA2389306C Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 03/25/2010 | WO2010033543A2 Novel compounds as cannabinoid receptor ligands |
| 03/25/2010 | WO2010033011A1 Rosamine derivatives as agents for the treatment of cancer |
| 03/25/2010 | WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same |
| 03/25/2010 | WO2010032200A1 Amide compounds useful in therapy |
| 03/25/2010 | WO2010031852A1 Novel estrogen receptor ligands |
| 03/25/2010 | WO2010031713A1 Substituted pyrrolidine-2-carboxamides |
| 03/25/2010 | WO2009154741A8 Thiophene or thiazole derivatives and their use as pi3k inhibitors |
| 03/25/2010 | US20100076205 Dye compound and dye-sensitized solar cell |